Cargando…

A DNA Methylation-Based Gene Signature Can Predict Triple-Negative Breast Cancer Diagnosis

Triple-negative breast cancer (TNBC) is the most aggressive breast cancer (BC) subtype and lacks targeted treatment. It is diagnosed by the absence of immunohistochemical expression of several biomarkers, but this method still displays some interlaboratory variability. DNA methylome aberrations are...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mendaza, Saioa, Guerrero-Setas, David, Monreal-Santesteban, Iñaki, Ulazia-Garmendia, Ane, Cordoba Iturriagagoitia, Alicia, De la Cruz, Susana, Martín-Sánchez, Esperanza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8533184/ https://www.ncbi.nlm.nih.gov/pubmed/34680511 http://dx.doi.org/10.3390/biomedicines9101394

Ejemplares similares

ADAM12 is A Potential Therapeutic Target Regulated by Hypomethylation in Triple-Negative Breast Cancer
por: Mendaza, Saioa, et al.
Publicado: (2020)

CDH22 hypermethylation is an independent prognostic biomarker in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer
por: Martín-Sánchez, Esperanza, et al.
Publicado: (2017)

Absence of Nuclear p16 Is a Diagnostic and Independent Prognostic Biomarker in Squamous Cell Carcinoma of the Cervix
por: Mendaza, Saioa, et al.
Publicado: (2020)

Understanding the Molecular Mechanism of miR-877-3p Could Provide Potential Biomarkers and Therapeutic Targets in Squamous Cell Carcinoma of the Cervix
por: Mendaza, Saioa, et al.
Publicado: (2021)

Identification of a DNA Methylation-Based Prognostic Signature for Patients with Triple-Negative Breast Cancer
por: Gao, Yinqi, et al.
Publicado: (2021)

Methylation profile of triple-negative breast carcinomas
por: Branham, M T, et al.
Publicado: (2012)

Distinct microbiological signatures associated with triple negative breast cancer
por: Banerjee, Sagarika, et al.
Publicado: (2015)

Identification of immunosuppressive signature subtypes and prognostic risk signatures in triple-negative breast cancer
por: Ding, Ran, et al.
Publicado: (2023)

Porokeratotic eccrine and hair follicle nevus: a report of two cases and review of the literature
por: Agulló-Pérez, Alfredo Daniel, et al.
Publicado: (2017)

Hemothorax as an Occult Cause of Hypotension After Transseptal Puncture
por: Iturriagagoitia, Arthur, et al.
Publicado: (2022)

Cytotoxic Lymphocyte-Related Gene Signature in Triple-Negative Breast Cancer
por: Han, Yiqun, et al.
Publicado: (2023)

Targeting DNA methylation for treating triple-negative breast cancer
por: Yu, Jia, et al.
Publicado: (2019)

Implication of m6A mRNA Methylation in Susceptibility to Inflammatory Bowel Disease
por: Sebastian-delaCruz, Maialen, et al.
Publicado: (2020)

MAGI2 Gene Region and Celiac Disease
por: Jauregi-Miguel, Amaia, et al.
Publicado: (2019)

A three-long noncoding RNA signature as a diagnostic biomarker for differentiating between triple-negative and non-triple-negative breast cancers
por: Liu, Man, et al.
Publicado: (2017)

A novel RT-QPCR-based assay for the relative quantification of residue specific m6A RNA methylation
por: Castellanos-Rubio, Ainara, et al.
Publicado: (2019)

Identification of long non-coding RNA signatures in triple-negative breast cancer
por: Tian, Tian, et al.
Publicado: (2018)

Autophagy-related prognostic signature for survival prediction of triple negative breast cancer
por: Yang, Qiong, et al.
Publicado: (2022)

An EMT-Related Gene Signature to Predict the Prognosis of Triple-Negative Breast Cancer
por: Zhang, Bo, et al.
Publicado: (2023)

Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
por: Gul, Samina, et al.
Publicado: (2023)

AR negative triple negative or “quadruple negative” breast cancers in African American women have an enriched basal and immune signature
por: Davis, Melissa, et al.
Publicado: (2018)

Age-related mutational signature negatively associated with immune activity and survival outcome in triple-negative breast cancer
por: Chen, Hao, et al.
Publicado: (2020)

A clinically relevant gene signature in triple negative and basal-like breast cancer
por: Rody, Achim, et al.
Publicado: (2011)

Novel immunohistochemistry-based signatures to predict metastatic site of triple-negative breast cancers
por: Klimov, Sergey, et al.
Publicado: (2017)

Three-microRNA expression signature predicts survival in triple-negative breast cancer
por: Wu, Xinquan, et al.
Publicado: (2020)

Mass Spectrometry-Based Omics for the Characterization of Triple-Negative Breast Cancer Bio-Signature
por: Pralea, Ioana-Ecaterina, et al.
Publicado: (2020)

Tumor microenvironment characterization in triple-negative breast cancer identifies prognostic gene signature
por: Qin, Yan, et al.
Publicado: (2021)

Application of mammography-based radiomics signature for preoperative prediction of triple-negative breast cancer
por: Ge, Shuai, et al.
Publicado: (2022)

Identification of immune-related signature for the prognosis and benefit of immunotherapy in triple-negative breast cancer
por: Sun, Xiaorui, et al.
Publicado: (2022)

MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial
por: Jank, Paul, et al.
Publicado: (2020)

A DNA methylation-based liquid biopsy for triple-negative breast cancer
por: Cristall, Katrina, et al.
Publicado: (2021)

Differential involvement of RASSF2 hypermethylation in breast cancer subtypes and their prognosis
por: Perez-Janices, Noemi, et al.
Publicado: (2015)

Update on systemic treatment in early triple negative breast cancer
por: Núñez Abad, Martín, et al.
Publicado: (2021)

WITHDRAWN: How Has the COVID-19 Pandemic and Lockdown Affected Breslow Thickness in Cutaneous Melanoma?
por: Sarriugarte Aldecoa-Otalora, J., et al.
Publicado: (2021)

[Translated article] How Has the COVID-19 Pandemic and Lockdown Affected Breslow Thickness in Cutaneous Melanoma?()
por: Sarriugarte Aldecoa-Otalora, J., et al.
Publicado: (2022)

¿Cómo ha afectado la pandemia y el confinamiento por COVID-19 al espesor de Breslow de los melanomas cutáneos?
por: Sarriugarte Aldecoa-Otalora, J., et al.
Publicado: (2022)

Homogeneous Datasets of Triple Negative Breast Cancers Enable the Identification of Novel Prognostic and Predictive Signatures
por: Karn, Thomas, et al.
Publicado: (2011)

Integrated MicroRNA and mRNA Signatures Associated with Survival in Triple Negative Breast Cancer
por: Cascione, Luciano, et al.
Publicado: (2013)

Comparative Proteome Analysis Revealing an 11-Protein Signature for Aggressive Triple-Negative Breast Cancer
por: Liu, Ning Qing, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_ddgp6hc3sso2fjgfe09r1ld5av